Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Low Back Pain | 15 | 2020 | 982 | 2.260 |
Why?
|
Pain Perception | 11 | 2018 | 196 | 1.860 |
Why?
|
Placebo Effect | 16 | 2021 | 518 | 1.750 |
Why?
|
Brain | 60 | 2024 | 27060 | 1.660 |
Why?
|
Schizophrenia | 35 | 2017 | 6927 | 1.630 |
Why?
|
Acupuncture Analgesia | 7 | 2021 | 63 | 1.560 |
Why?
|
Prefrontal Cortex | 19 | 2021 | 2218 | 1.550 |
Why?
|
Brain Mapping | 38 | 2021 | 6603 | 1.510 |
Why?
|
Pain Threshold | 12 | 2021 | 603 | 1.440 |
Why?
|
Acupuncture Therapy | 8 | 2020 | 485 | 1.370 |
Why?
|
Memory, Short-Term | 12 | 2015 | 981 | 1.220 |
Why?
|
Magnetic Resonance Imaging | 86 | 2022 | 36362 | 1.180 |
Why?
|
Pain | 23 | 2021 | 5075 | 1.180 |
Why?
|
Neural Pathways | 20 | 2020 | 3049 | 1.160 |
Why?
|
Cerebral Cortex | 21 | 2020 | 5764 | 1.000 |
Why?
|
Pain Measurement | 24 | 2020 | 3546 | 0.950 |
Why?
|
Periaqueductal Gray | 5 | 2015 | 110 | 0.890 |
Why?
|
Catechol O-Methyltransferase | 6 | 2014 | 251 | 0.850 |
Why?
|
Image Processing, Computer-Assisted | 27 | 2021 | 8967 | 0.850 |
Why?
|
Hyperalgesia | 6 | 2021 | 530 | 0.770 |
Why?
|
Osteoarthritis, Knee | 6 | 2018 | 1241 | 0.750 |
Why?
|
Nerve Net | 10 | 2020 | 2283 | 0.730 |
Why?
|
Hippocampus | 10 | 2017 | 3755 | 0.680 |
Why?
|
Arthralgia | 2 | 2018 | 463 | 0.560 |
Why?
|
Somatosensory Cortex | 3 | 2020 | 511 | 0.540 |
Why?
|
Young Adult | 54 | 2021 | 59068 | 0.510 |
Why?
|
Memory Disorders | 4 | 2014 | 1198 | 0.500 |
Why?
|
Frontal Lobe | 8 | 2015 | 1420 | 0.480 |
Why?
|
Adult | 94 | 2021 | 220781 | 0.460 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2017 | 15867 | 0.460 |
Why?
|
Longevity | 1 | 2021 | 1062 | 0.440 |
Why?
|
Basal Ganglia | 4 | 2019 | 554 | 0.430 |
Why?
|
Music Therapy | 1 | 2014 | 110 | 0.420 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2014 | 306 | 0.420 |
Why?
|
Diffusion Magnetic Resonance Imaging | 9 | 2017 | 2788 | 0.410 |
Why?
|
Genome-Wide Association Study | 8 | 2020 | 12653 | 0.400 |
Why?
|
Empathy | 2 | 2020 | 473 | 0.400 |
Why?
|
Analgesia | 3 | 2021 | 460 | 0.400 |
Why?
|
Genetic Loci | 5 | 2020 | 2626 | 0.400 |
Why?
|
Cognition Disorders | 8 | 2017 | 3975 | 0.380 |
Why?
|
Rest | 6 | 2019 | 915 | 0.370 |
Why?
|
Male | 98 | 2024 | 360035 | 0.370 |
Why?
|
Lateral Thalamic Nuclei | 1 | 2020 | 9 | 0.370 |
Why?
|
Catastrophization | 3 | 2019 | 348 | 0.360 |
Why?
|
Ventral Thalamic Nuclei | 1 | 2020 | 43 | 0.360 |
Why?
|
Female | 100 | 2024 | 391875 | 0.350 |
Why?
|
Temporal Lobe | 6 | 2012 | 1690 | 0.350 |
Why?
|
Neostriatum | 1 | 2011 | 246 | 0.340 |
Why?
|
Agnosia | 1 | 2020 | 66 | 0.340 |
Why?
|
Humans | 137 | 2024 | 760437 | 0.330 |
Why?
|
Consciousness | 2 | 2015 | 601 | 0.330 |
Why?
|
Electroacupuncture | 2 | 2010 | 66 | 0.330 |
Why?
|
Middle Aged | 59 | 2024 | 220382 | 0.320 |
Why?
|
Acupuncture Points | 4 | 2013 | 111 | 0.320 |
Why?
|
Touch Perception | 1 | 2020 | 106 | 0.320 |
Why?
|
Gyrus Cinguli | 7 | 2019 | 1115 | 0.300 |
Why?
|
Organ Size | 7 | 2020 | 2252 | 0.290 |
Why?
|
Image Interpretation, Computer-Assisted | 9 | 2012 | 3346 | 0.290 |
Why?
|
Cognition | 8 | 2024 | 6973 | 0.290 |
Why?
|
Thalamus | 7 | 2014 | 1043 | 0.290 |
Why?
|
Reward | 4 | 2020 | 970 | 0.290 |
Why?
|
Nerve Tissue Proteins | 3 | 2017 | 4413 | 0.290 |
Why?
|
Genetic Variation | 3 | 2020 | 6570 | 0.280 |
Why?
|
Myelin Sheath | 2 | 2015 | 653 | 0.280 |
Why?
|
Parietal Lobe | 3 | 2015 | 850 | 0.280 |
Why?
|
Oxygen | 10 | 2018 | 4222 | 0.270 |
Why?
|
Amygdala | 4 | 2019 | 1353 | 0.270 |
Why?
|
Fibromyalgia | 3 | 2015 | 403 | 0.270 |
Why?
|
Caffeine | 1 | 2021 | 700 | 0.260 |
Why?
|
Hot Temperature | 4 | 2015 | 1440 | 0.260 |
Why?
|
Neuropsychological Tests | 12 | 2017 | 7029 | 0.250 |
Why?
|
Attention | 4 | 2021 | 2391 | 0.240 |
Why?
|
Back Pain | 1 | 2019 | 545 | 0.240 |
Why?
|
Video Recording | 1 | 2019 | 962 | 0.230 |
Why?
|
Autonomic Nervous System | 1 | 2019 | 701 | 0.220 |
Why?
|
DNA Methylation | 2 | 2015 | 4383 | 0.220 |
Why?
|
Medical Informatics | 3 | 2010 | 733 | 0.220 |
Why?
|
Physical Stimulation | 4 | 2019 | 518 | 0.220 |
Why?
|
Placebos | 5 | 2019 | 1661 | 0.220 |
Why?
|
Genetic Predisposition to Disease | 8 | 2017 | 17854 | 0.210 |
Why?
|
Models, Neurological | 3 | 2012 | 1765 | 0.210 |
Why?
|
Schizophrenic Psychology | 4 | 2015 | 1647 | 0.200 |
Why?
|
Maternal Behavior | 1 | 2014 | 307 | 0.200 |
Why?
|
Functional Laterality | 6 | 2014 | 2253 | 0.200 |
Why?
|
Adolescent | 22 | 2021 | 88196 | 0.200 |
Why?
|
Conditioning, Classical | 1 | 2014 | 365 | 0.200 |
Why?
|
Emotions | 3 | 2015 | 2735 | 0.200 |
Why?
|
Corpus Callosum | 3 | 2017 | 749 | 0.200 |
Why?
|
Biomedical Research | 4 | 2015 | 3421 | 0.200 |
Why?
|
Cues | 4 | 2014 | 874 | 0.200 |
Why?
|
Psychomotor Performance | 1 | 2020 | 1880 | 0.200 |
Why?
|
Diffusion Tensor Imaging | 6 | 2020 | 2399 | 0.190 |
Why?
|
Nervous System | 1 | 2015 | 543 | 0.190 |
Why?
|
Neuronal Plasticity | 1 | 2020 | 1434 | 0.190 |
Why?
|
Epigenesis, Genetic | 1 | 2015 | 3782 | 0.190 |
Why?
|
Diprenorphine | 2 | 2014 | 13 | 0.190 |
Why?
|
Diagnostic Imaging | 4 | 2022 | 3541 | 0.190 |
Why?
|
Cerebral Infarction | 2 | 2014 | 982 | 0.190 |
Why?
|
Mother-Child Relations | 1 | 2014 | 494 | 0.180 |
Why?
|
Visual Perception | 1 | 2019 | 1379 | 0.180 |
Why?
|
Analysis of Variance | 5 | 2021 | 6230 | 0.180 |
Why?
|
Biomarkers, Pharmacological | 1 | 2011 | 162 | 0.180 |
Why?
|
Personality | 1 | 2014 | 554 | 0.180 |
Why?
|
Cross-Over Studies | 4 | 2021 | 2073 | 0.180 |
Why?
|
Principal Component Analysis | 3 | 2014 | 943 | 0.170 |
Why?
|
Leukoencephalopathies | 2 | 2012 | 252 | 0.160 |
Why?
|
Single-Blind Method | 3 | 2020 | 1571 | 0.160 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2013 | 952 | 0.160 |
Why?
|
Psychophysics | 3 | 2015 | 289 | 0.160 |
Why?
|
MicroRNAs | 1 | 2015 | 3796 | 0.160 |
Why?
|
Anisotropy | 5 | 2020 | 1283 | 0.160 |
Why?
|
Homeodomain Proteins | 3 | 2018 | 2413 | 0.150 |
Why?
|
Databases, Factual | 3 | 2018 | 7948 | 0.150 |
Why?
|
Genetic Association Studies | 4 | 2015 | 2723 | 0.150 |
Why?
|
Sex Characteristics | 2 | 2015 | 2633 | 0.150 |
Why?
|
Technology Transfer | 1 | 2008 | 42 | 0.150 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2021 | 3702 | 0.150 |
Why?
|
Motivation | 1 | 2018 | 2006 | 0.150 |
Why?
|
Child | 14 | 2021 | 80086 | 0.150 |
Why?
|
Beta Rhythm | 1 | 2018 | 63 | 0.150 |
Why?
|
Skull | 2 | 2018 | 818 | 0.140 |
Why?
|
Food, Fortified | 1 | 2018 | 189 | 0.140 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1737 | 0.140 |
Why?
|
Genes, Homeobox | 1 | 2018 | 285 | 0.140 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2017 | 91 | 0.140 |
Why?
|
Methionine Sulfoxide Reductases | 1 | 2017 | 77 | 0.140 |
Why?
|
Case-Control Studies | 12 | 2020 | 22097 | 0.140 |
Why?
|
Aged | 20 | 2024 | 168840 | 0.130 |
Why?
|
Aged, 80 and over | 10 | 2021 | 58859 | 0.130 |
Why?
|
Database Management Systems | 1 | 2007 | 257 | 0.130 |
Why?
|
Algorithms | 7 | 2019 | 14002 | 0.130 |
Why?
|
Neural Tube Defects | 1 | 2018 | 254 | 0.130 |
Why?
|
Learning | 1 | 2015 | 1740 | 0.130 |
Why?
|
Neurosciences | 1 | 2010 | 364 | 0.130 |
Why?
|
Cohort Studies | 10 | 2021 | 41366 | 0.130 |
Why?
|
Neuralgia | 1 | 2012 | 611 | 0.130 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2019 | 352 | 0.130 |
Why?
|
Infant, Newborn | 6 | 2021 | 26280 | 0.130 |
Why?
|
Phenotype | 5 | 2016 | 16585 | 0.130 |
Why?
|
Vision, Ocular | 1 | 2009 | 454 | 0.130 |
Why?
|
Narcotics | 1 | 1997 | 336 | 0.120 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11900 | 0.120 |
Why?
|
Brain Injuries | 1 | 2017 | 2049 | 0.120 |
Why?
|
Receptors, Neurotransmitter | 1 | 1995 | 174 | 0.120 |
Why?
|
Nucleus Accumbens | 1 | 1997 | 365 | 0.120 |
Why?
|
Auditory Cortex | 1 | 2009 | 363 | 0.120 |
Why?
|
Second Messenger Systems | 1 | 1995 | 202 | 0.120 |
Why?
|
Mental Status Schedule | 1 | 2015 | 314 | 0.120 |
Why?
|
Evoked Potentials | 1 | 2010 | 1037 | 0.110 |
Why?
|
Neurogranin | 1 | 2013 | 15 | 0.110 |
Why?
|
Photic Stimulation | 3 | 2015 | 1971 | 0.110 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4760 | 0.110 |
Why?
|
Child, Preschool | 7 | 2021 | 42209 | 0.110 |
Why?
|
Smoking | 3 | 2013 | 9046 | 0.110 |
Why?
|
Cortical Synchronization | 1 | 2014 | 77 | 0.110 |
Why?
|
Pattern Recognition, Automated | 1 | 2010 | 996 | 0.110 |
Why?
|
Putamen | 1 | 2015 | 292 | 0.110 |
Why?
|
Apraxias | 1 | 2014 | 59 | 0.110 |
Why?
|
Corpus Striatum | 2 | 2014 | 1235 | 0.110 |
Why?
|
Infant | 6 | 2021 | 36183 | 0.110 |
Why?
|
Caudate Nucleus | 1 | 2015 | 389 | 0.110 |
Why?
|
Migraine Disorders | 1 | 2016 | 1697 | 0.110 |
Why?
|
Drug Discovery | 1 | 2011 | 1054 | 0.110 |
Why?
|
Cerebellum | 2 | 2012 | 1500 | 0.110 |
Why?
|
Punishment | 1 | 2014 | 95 | 0.110 |
Why?
|
Statistics, Nonparametric | 2 | 2017 | 2852 | 0.110 |
Why?
|
Diffusion of Innovation | 1 | 2008 | 726 | 0.100 |
Why?
|
Gene Duplication | 1 | 2014 | 314 | 0.100 |
Why?
|
Thinking | 1 | 2016 | 320 | 0.100 |
Why?
|
Parahippocampal Gyrus | 1 | 2013 | 115 | 0.100 |
Why?
|
Cerebrovascular Circulation | 2 | 2011 | 2728 | 0.100 |
Why?
|
Cocaine | 1 | 1997 | 958 | 0.100 |
Why?
|
Glutamate Decarboxylase | 1 | 2013 | 239 | 0.100 |
Why?
|
Problem Solving | 1 | 2004 | 441 | 0.100 |
Why?
|
Acoustic Stimulation | 2 | 2010 | 1234 | 0.100 |
Why?
|
Positron-Emission Tomography | 3 | 2014 | 6475 | 0.100 |
Why?
|
Folic Acid | 1 | 2018 | 1315 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 1 | 2017 | 1075 | 0.100 |
Why?
|
Visual Cortex | 1 | 2009 | 1094 | 0.090 |
Why?
|
Carotid Artery, Internal | 1 | 2013 | 440 | 0.090 |
Why?
|
Attitude to Health | 1 | 2010 | 2025 | 0.090 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2012 | 246 | 0.090 |
Why?
|
GTP-Binding Proteins | 1 | 1995 | 950 | 0.090 |
Why?
|
Mental Disorders | 3 | 2010 | 6831 | 0.090 |
Why?
|
Radiology Information Systems | 1 | 2015 | 528 | 0.090 |
Why?
|
Drosophila melanogaster | 1 | 2019 | 1709 | 0.090 |
Why?
|
Spin Labels | 2 | 2012 | 338 | 0.090 |
Why?
|
Severity of Illness Index | 7 | 2018 | 15820 | 0.090 |
Why?
|
Geriatric Assessment | 1 | 2007 | 1409 | 0.090 |
Why?
|
Serotonin | 1 | 1994 | 1040 | 0.080 |
Why?
|
Physician-Patient Relations | 1 | 2013 | 3246 | 0.080 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 819 | 0.080 |
Why?
|
Dementia | 1 | 2024 | 2679 | 0.080 |
Why?
|
Quantitative Trait, Heritable | 1 | 2012 | 542 | 0.080 |
Why?
|
Glycoproteins | 1 | 2017 | 2207 | 0.080 |
Why?
|
Medical Records Systems, Computerized | 1 | 2015 | 1191 | 0.080 |
Why?
|
Forearm | 2 | 2012 | 427 | 0.080 |
Why?
|
Multicenter Studies as Topic | 3 | 2009 | 1703 | 0.080 |
Why?
|
Sensory Thresholds | 1 | 2020 | 377 | 0.080 |
Why?
|
Brain Diseases | 1 | 2008 | 1544 | 0.080 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2013 | 538 | 0.080 |
Why?
|
Extremities | 1 | 2014 | 867 | 0.080 |
Why?
|
Qi | 1 | 2007 | 15 | 0.080 |
Why?
|
Transcription Factors | 3 | 2018 | 12121 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9410 | 0.080 |
Why?
|
Sleep | 1 | 2024 | 4760 | 0.070 |
Why?
|
Population Surveillance | 1 | 2018 | 2603 | 0.070 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2014 | 6019 | 0.070 |
Why?
|
Executive Function | 1 | 2016 | 1383 | 0.070 |
Why?
|
Membrane Proteins | 2 | 2015 | 7849 | 0.070 |
Why?
|
Aging | 2 | 2018 | 8689 | 0.070 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2008 | 276 | 0.070 |
Why?
|
Galvanic Skin Response | 2 | 2015 | 351 | 0.070 |
Why?
|
Reaction Time | 3 | 2009 | 2078 | 0.070 |
Why?
|
Meditation | 1 | 2000 | 251 | 0.070 |
Why?
|
Neurons, Afferent | 1 | 2019 | 498 | 0.070 |
Why?
|
Genotype | 5 | 2017 | 12976 | 0.070 |
Why?
|
Random Allocation | 1 | 2021 | 2388 | 0.070 |
Why?
|
Chronic Disease | 4 | 2014 | 9309 | 0.070 |
Why?
|
Carotid Stenosis | 1 | 2013 | 860 | 0.070 |
Why?
|
Tobacco Use Disorder | 1 | 2012 | 703 | 0.070 |
Why?
|
Polymorphism, Genetic | 2 | 2014 | 4287 | 0.060 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2502 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2014 | 5126 | 0.060 |
Why?
|
Multifactorial Inheritance | 1 | 2013 | 1378 | 0.060 |
Why?
|
Subliminal Stimulation | 1 | 2014 | 8 | 0.060 |
Why?
|
Information Dissemination | 1 | 2013 | 1127 | 0.060 |
Why?
|
Physicians | 1 | 2013 | 4586 | 0.060 |
Why?
|
Needles | 1 | 2007 | 451 | 0.060 |
Why?
|
Perceptual Masking | 1 | 2014 | 90 | 0.060 |
Why?
|
Double-Blind Method | 2 | 2021 | 12320 | 0.060 |
Why?
|
Personality Tests | 1 | 2014 | 82 | 0.060 |
Why?
|
Capsaicin | 1 | 2015 | 231 | 0.060 |
Why?
|
Mental Processes | 1 | 2015 | 245 | 0.060 |
Why?
|
Atlases as Topic | 1 | 2015 | 247 | 0.060 |
Why?
|
Peripheral Nerves | 1 | 2007 | 479 | 0.060 |
Why?
|
Regression Analysis | 2 | 2014 | 6340 | 0.060 |
Why?
|
Reproducibility of Results | 6 | 2015 | 20078 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3609 | 0.050 |
Why?
|
Systems Integration | 2 | 2015 | 426 | 0.050 |
Why?
|
Internet | 1 | 2006 | 3092 | 0.050 |
Why?
|
Motor Cortex | 1 | 2010 | 1003 | 0.050 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 2629 | 0.050 |
Why?
|
Tomography, Emission-Computed | 1 | 1996 | 1122 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5778 | 0.050 |
Why?
|
Brain Stem | 2 | 2012 | 858 | 0.050 |
Why?
|
Anticipation, Psychological | 1 | 2012 | 85 | 0.050 |
Why?
|
Uncertainty | 1 | 2017 | 753 | 0.050 |
Why?
|
Longitudinal Studies | 3 | 2020 | 14565 | 0.050 |
Why?
|
Lidocaine | 1 | 2015 | 540 | 0.050 |
Why?
|
Treatment Outcome | 6 | 2020 | 64591 | 0.050 |
Why?
|
Software | 1 | 2006 | 4426 | 0.050 |
Why?
|
Hypnosis | 1 | 2012 | 82 | 0.050 |
Why?
|
Neurofeedback | 1 | 2012 | 44 | 0.050 |
Why?
|
Suicidal Ideation | 1 | 2021 | 1443 | 0.050 |
Why?
|
Antipsychotic Agents | 2 | 2013 | 3066 | 0.050 |
Why?
|
Autopsy | 1 | 2014 | 1005 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 1997 | 4416 | 0.050 |
Why?
|
Sleep, REM | 1 | 2024 | 594 | 0.040 |
Why?
|
Awareness | 1 | 2014 | 647 | 0.040 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2013 | 370 | 0.040 |
Why?
|
Pressure | 1 | 2013 | 1155 | 0.040 |
Why?
|
Dogs | 1 | 2014 | 3839 | 0.040 |
Why?
|
Statistics as Topic | 2 | 2011 | 2357 | 0.040 |
Why?
|
Discriminant Analysis | 1 | 2009 | 222 | 0.040 |
Why?
|
Acetaminophen | 1 | 2013 | 554 | 0.040 |
Why?
|
Research Design | 2 | 2011 | 6168 | 0.040 |
Why?
|
Apoptosis | 1 | 2015 | 9468 | 0.040 |
Why?
|
Apraxia, Ideomotor | 1 | 2018 | 4 | 0.040 |
Why?
|
Reference Values | 3 | 2012 | 4921 | 0.040 |
Why?
|
Illusions | 1 | 2008 | 61 | 0.040 |
Why?
|
Physical Therapy Modalities | 1 | 2012 | 536 | 0.040 |
Why?
|
Mutation | 3 | 2018 | 30025 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2015 | 1496 | 0.040 |
Why?
|
Anesthetics, Local | 1 | 2015 | 998 | 0.040 |
Why?
|
Philadelphia | 1 | 2018 | 266 | 0.040 |
Why?
|
Afferent Pathways | 1 | 2009 | 298 | 0.040 |
Why?
|
Mood Disorders | 1 | 2014 | 1127 | 0.040 |
Why?
|
Cooperative Behavior | 2 | 2014 | 1504 | 0.040 |
Why?
|
Psychomotor Disorders | 1 | 2008 | 149 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15257 | 0.040 |
Why?
|
Models, Biological | 1 | 2014 | 9462 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4063 | 0.040 |
Why?
|
Self Report | 1 | 2019 | 3721 | 0.040 |
Why?
|
Disability Evaluation | 1 | 2014 | 1834 | 0.040 |
Why?
|
Pons | 1 | 2008 | 240 | 0.030 |
Why?
|
Carbon Radioisotopes | 1 | 2008 | 562 | 0.030 |
Why?
|
Nonlinear Dynamics | 2 | 2012 | 493 | 0.030 |
Why?
|
Down Syndrome | 2 | 2016 | 898 | 0.030 |
Why?
|
Oncogene Protein v-akt | 1 | 2016 | 129 | 0.030 |
Why?
|
Psychotic Disorders | 1 | 2011 | 3208 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2015 | 10180 | 0.030 |
Why?
|
Vitamin B Complex | 1 | 2018 | 298 | 0.030 |
Why?
|
Endophenotypes | 1 | 2017 | 255 | 0.030 |
Why?
|
Information Management | 1 | 2006 | 100 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 2017 | 8579 | 0.030 |
Why?
|
Sodium Chloride | 1 | 1997 | 588 | 0.030 |
Why?
|
Hand Strength | 1 | 2018 | 456 | 0.030 |
Why?
|
Reading | 1 | 2008 | 529 | 0.030 |
Why?
|
Radiography | 2 | 2013 | 6963 | 0.030 |
Why?
|
Neural Inhibition | 1 | 2009 | 589 | 0.030 |
Why?
|
Prevalence | 2 | 2014 | 15698 | 0.030 |
Why?
|
Animals | 6 | 2019 | 168253 | 0.030 |
Why?
|
Fragile X Syndrome | 1 | 2016 | 116 | 0.030 |
Why?
|
Behavior | 1 | 1997 | 540 | 0.030 |
Why?
|
Probability | 1 | 2019 | 2476 | 0.030 |
Why?
|
Parkinson Disease | 2 | 2020 | 2875 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2019 | 892 | 0.030 |
Why?
|
Receptors, Opioid | 1 | 2014 | 145 | 0.030 |
Why?
|
Ondansetron | 1 | 1994 | 95 | 0.030 |
Why?
|
Sensory Receptor Cells | 1 | 2009 | 512 | 0.030 |
Why?
|
Age Factors | 1 | 2020 | 18379 | 0.030 |
Why?
|
Receptors, Serotonin | 1 | 1994 | 208 | 0.030 |
Why?
|
Magnetoencephalography | 1 | 2018 | 636 | 0.030 |
Why?
|
Electric Stimulation | 1 | 2009 | 1735 | 0.030 |
Why?
|
Circle of Willis | 1 | 2013 | 78 | 0.030 |
Why?
|
Psychiatry | 1 | 1996 | 1690 | 0.030 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2013 | 98 | 0.030 |
Why?
|
Databases, Bibliographic | 1 | 2013 | 130 | 0.030 |
Why?
|
Interneurons | 1 | 2018 | 593 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2009 | 1859 | 0.030 |
Why?
|
Odds Ratio | 1 | 2014 | 9639 | 0.030 |
Why?
|
Lithium | 1 | 1995 | 596 | 0.020 |
Why?
|
Depression | 1 | 2021 | 8104 | 0.020 |
Why?
|
Organizational Innovation | 1 | 2015 | 536 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2018 | 1135 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2008 | 1988 | 0.020 |
Why?
|
Down-Regulation | 1 | 2009 | 2911 | 0.020 |
Why?
|
Indians, North American | 1 | 1995 | 353 | 0.020 |
Why?
|
Valine | 1 | 2013 | 408 | 0.020 |
Why?
|
Antimanic Agents | 1 | 1995 | 520 | 0.020 |
Why?
|
Oligodendroglia | 1 | 2015 | 538 | 0.020 |
Why?
|
Stroke | 1 | 2013 | 9745 | 0.020 |
Why?
|
Methionine | 1 | 2013 | 572 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 26063 | 0.020 |
Why?
|
Perception | 1 | 2007 | 1196 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2017 | 4789 | 0.020 |
Why?
|
Narcotic Antagonists | 1 | 2014 | 585 | 0.020 |
Why?
|
Cerebral Ventricles | 1 | 2012 | 542 | 0.020 |
Why?
|
Image Enhancement | 1 | 2010 | 2882 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2014 | 1376 | 0.020 |
Why?
|
Risk Factors | 3 | 2021 | 74055 | 0.020 |
Why?
|
Verbal Learning | 1 | 2011 | 463 | 0.020 |
Why?
|
Homozygote | 1 | 2013 | 1794 | 0.020 |
Why?
|
Mesencephalon | 1 | 2000 | 332 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4923 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2860 | 0.020 |
Why?
|
Intelligence | 1 | 2012 | 924 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3418 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2013 | 1433 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2011 | 1183 | 0.020 |
Why?
|
Pregnancy | 2 | 2018 | 29831 | 0.020 |
Why?
|
Time Factors | 1 | 2018 | 39947 | 0.020 |
Why?
|
Sex Factors | 1 | 2009 | 10538 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8826 | 0.020 |
Why?
|
Signal Transduction | 1 | 2008 | 23397 | 0.020 |
Why?
|
Pattern Recognition, Visual | 1 | 2011 | 813 | 0.020 |
Why?
|
Pyramidal Tracts | 1 | 2007 | 252 | 0.020 |
Why?
|
Comorbidity | 1 | 2010 | 10494 | 0.020 |
Why?
|
Pilot Projects | 1 | 2008 | 8611 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14661 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2008 | 7817 | 0.010 |
Why?
|
Arousal | 1 | 2000 | 1162 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7996 | 0.010 |
Why?
|
Respiration | 1 | 2000 | 1657 | 0.010 |
Why?
|
Nerve Fibers | 1 | 2007 | 708 | 0.010 |
Why?
|
Calibration | 1 | 2005 | 818 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39078 | 0.010 |
Why?
|
Cell Count | 1 | 2007 | 1834 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6908 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5865 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18216 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9605 | 0.010 |
Why?
|
Dopamine | 1 | 2008 | 1603 | 0.010 |
Why?
|
Observer Variation | 1 | 2007 | 2604 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7582 | 0.010 |
Why?
|
Quality Improvement | 1 | 2015 | 3798 | 0.010 |
Why?
|
Computational Biology | 1 | 2011 | 3510 | 0.010 |
Why?
|
Neurons | 1 | 2018 | 9443 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10759 | 0.010 |
Why?
|
Research | 1 | 1996 | 1977 | 0.010 |
Why?
|
Asthma | 1 | 1995 | 6195 | 0.010 |
Why?
|
United States | 2 | 2008 | 72202 | 0.010 |
Why?
|
New Mexico | 1 | 1995 | 83 | 0.010 |
Why?
|
Computer Simulation | 1 | 2005 | 6230 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2013 | 80430 | 0.000 |
Why?
|